ViPOR: Novel Targeted Therapy Combination Shows Potential in Relapsed DLBCL
Epcoritamab Gets Label Expansion for Difficult-to-Treat R/R Follicular Lymphoma
Polatuzumab Vedotin: Review Spotlights Its Use, Promise in DLBCL
Case Reports: Managing DLBCL Associated With Papillary Thyroid Carcinoma
Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Review Highlights Potential for Bispecific Antibodies in DLBCL
Biosimilar HLX01 Demonstrates Bioequivalence With Rituxan in DLBCL